0001104659-19-012433.txt : 20190304
0001104659-19-012433.hdr.sgml : 20190304
20190304160243
ACCESSION NUMBER: 0001104659-19-012433
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190301
FILED AS OF DATE: 20190304
DATE AS OF CHANGE: 20190304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McLaughlin Gerald W.
CENTRAL INDEX KEY: 0001495412
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37508
FILM NUMBER: 19653692
MAIL ADDRESS:
STREET 1: 227 WASHINGTON STREET
STREET 2: SUITE 200
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001467652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270395455
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2940 N. HIGHWAY 360
STREET 2: SUITE 400
CITY: GRAND PRAIRIE
STATE: TX
ZIP: 75050
BUSINESS PHONE: 972.408.1360
MAIL ADDRESS:
STREET 1: 2940 N. HIGHWAY 360
STREET 2: SUITE 400
CITY: GRAND PRAIRIE
STATE: TX
ZIP: 75050
4
1
a4.xml
4
X0306
4
2019-03-01
0
0001467652
Neos Therapeutics, Inc.
NEOS
0001495412
McLaughlin Gerald W.
C/O NEOS THERAPEUTICS, INC.
2940 N. HWY 360
GRAND PRAIRIE
TX
75050
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
2.31
2019-03-01
4
A
0
523583
0
A
2029-03-01
Common Stock
523583
523583
D
This stock option will vest in four equal, annual installments beginning on March 1, 2019.
/s/ Richard Eisenstadt, attorney in fact
2019-03-04